Navigation Links
Verenium Reports Financial Results For The First Quarter Ended March 31, 2013
Date:5/9/2013

ed by significant non-recurring and non-cash items. The Company believes that reporting Adjusted EBITDA on a non-GAAP basis, which excludes the impact of these items, provides a more consistent measure of operating results. It should not be considered, however, in isolation or as a substitute for, or superior to, the financial information presented in the Company's consolidated financial statements.  Further, the Adjusted EBITDA measure shown for the Company may not be comparable to similarly titled measures used by other companies.

The Company reported Adjusted EBITDA loss of $2.5 million for the quarter ended March 31, 2013, compared to Adjusted EBITDA income of $1.4 million for the same quarter in the prior year.  The change in Adjusted EBITDA is primarily attributed to license revenue recorded in 2012 from DSM and Novus International, and increased research and development expenses.

Balance Sheet

The Company ended the quarter with $27.2 million in cash and cash equivalents and $2.5 million in total restricted cash.

"First quarter results are in line with our expectations, reflecting continued steady demand for our Phyzyme® XP phytase product for animal health and nutrition," said James Levine, President & Chief Executive Officer at Verenium.  "Our recent successful corn ethanol plant trial activity demonstrates a strong value proposition for customers in a challenged market, and gives us reason to believe our Grain Processing enzymes will be an important source of revenue growth."

Financial Guidance for 2013Verenium also provided financial guidance for 2013, as follows:

  • Adjusted EBITDA: $(10) – $(12) million
  • Capital Expenditures: $3 - $4 million
  • "The financial guidance we are providing today is based on our expectation of moderate growth in product revenue and product gross profit from our existing commercial products," said Jeff Black, Chief Financial
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012
    2. Verenium To Present At Upcoming Conferences
    3. Verenium To Present At The Jefferies 2012 Global Industrial And Aerospace & Defense Conference
    4. Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference
    5. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
    6. Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
    7. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
    8. Chindex International, Inc. Reports First Quarter 2013 Financial Results
    9. BioScrip Reports First Quarter 2013 Financial Results
    10. China Biologic Reports Financial Results for the First Quarter of 2013
    11. Nephros Reports First Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... 2014 Research and Markets  has announced the ... 2014" report to their offering. The ... of the largest segments of pharmaceuticals industry. The numbers of ... available therapies were unable to meet the market requirements. There ... CNS disorder, especially over the past two decades. The market ...
    (Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , a ... announced today that T. (Teo) Forcht Dagi , ... company,s Board of Directors. " Teo Forcht ... in neurosurgery, medical innovation and venture capital," said Remis ... delighted to add his clinical, strategic, and entrepreneurial expertise to ...
    (Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
    Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
    ... stimulants combined provide greater improvement in symptoms ... Addrenex Pharmaceuticals, Inc. today announced positive results ... Clonicel demonstrating that the combination of Clonicel ... in attention deficit hyperactivity disorder (ADHD) symptoms ...
    ... After a review of several vendors, the University ... selected the services of Velos and its flagship product, ... implemented at UCLA,s Jonsson Comprehensive Cancer Center and an ... Plans are in place to deploy the system in ...
    Cached Medicine Technology:Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication 2University of California Los Angeles Selects Velos eResearch 2University of California Los Angeles Selects Velos eResearch 3University of California Los Angeles Selects Velos eResearch 4University of California Los Angeles Selects Velos eResearch 5University of California Los Angeles Selects Velos eResearch 6
    (Date:8/29/2014)... yoga month was created by the Yoga Health Foundation ... To support this Ekhart Yoga is offering those interested ... This 4 week guided online yoga program is especially ... regularly from their own home. Led by Esther Ekhart, ... all levels, and the dynamic classes will help build ...
    (Date:8/29/2014)... (PRWEB) August 29, 2014 Senior ... of operations & business development. , Rees has been ... president of business development. , A wholly owned subsidiary ... Independence provides older adults with options, including personalized home ... care (e.g., meal preparation) and therapeutic adult day centers. ...
    (Date:8/29/2014)... University of Houston Graduate College of Social Work is the ... million grant from the National Institute of Drug Abuse (NIDA) ... long-term use and health consequences of heroin use. Additionally, the ... future research endeavors. , Heroin use has increased ... prescription pain medication abuse to the cheaper and more available ...
    (Date:8/29/2014)... 2014 Last week, the Fed reported ... monthly gain. Industrial production rose to 0.4% while manufacturing output ... is the single largest boost since February this year. Capacity ... since February as well – an increase that could be ... to a 79.2% rate, which is a measure of slack ...
    (Date:8/29/2014)... R.I. (PRWEB) August 29, 2014 A home should ... crop up if unaddressed. That’s why Amica Insurance is sharing some ... National Safety Council suggests taking the following safety measures: , Kitchen, ... disinfectants – in their original containers, and keep them away from ... a wall bracket near an exit. , Bathroom , ...
    Breaking Medicine News(10 mins):Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2Health News:$1.25 million NIH grant to aid research on impact of heroin use 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Improve Home Safety with Tips from Amica Insurance 2
    ... Over Estimated,A UK doctor, and a leading expert warned ... are being overstated, leading to unnecessary panic. // ... Tyne said there was very little evidence suggesting that ... nut allergies had saved lives. ,Writing in ...
    ... A team from the Medical Research Council suggests that ... triggered by the presence of a hormone in semen.// ... the development of tumors. ,In a report in ... recommend that women having either cancer should ask their ...
    ... night’s sleep is critical to doing well in school because ... in class and while doing homework.// While this is common ... can be complex; and the rewards for treatment can extend ... be getting a good night’s sleep is that he or ...
    ... cases in Africa as of last year hover around ... Nations //.The World Health Organization has suggested an intelligent ... ,The WHO has advised that the ... Africa could be used to give an impetus to ...
    ... emergency unit is said to make patients wait longer than ... ,This news has only added salt to the ... procedures at the ERI following its branding as one of ... ,Recent figures have shown that more than a third of ...
    ... government today introduced a controversial licensing scheme. According to ... will be permitted to describe the ailments they claim ... aim to bring homeopathic remedies into the area of ... doctors and scientists believe that products with no scientific ...
    Cached Medicine News:Health News:Inordinately Long Waiting Times at A&E Infirmary 2Health News:Doctors worried about Homeopathic licensing 2
    ... be used only with the E3671 twisted snare ... the wing nut and the loop can be ... ratchet so that the loop can be slipped ... length - 5.6 inches. Comes with one package ...
    Open 14 mm fixation ring with teeth to prevent damage to conjuctiva. Gauge is marked every 10 degrees to determine the extent of the arc to be incised. Two broad marks align with steep axis....
    ... Titanium. Designed to fixate the ... The two-sided ring can easily ... pointed or smooth side on ... pressure to the eye to ...
    For sterilizing, carrying and storage of a Storz diamond knife and barrel gauge....
    Medicine Products: